Dopamine and cAMP-Regulated Phosphoprotein 32
"Dopamine and cAMP-Regulated Phosphoprotein 32" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phosphoprotein that was initially identified as a major target of DOPAMINE activated ADENYLYL CYCLASE in the CORPUS STRIATUM. It regulates the activities of PROTEIN PHOSPHATASE-1 and PROTEIN KINASE A, and it is a key mediator of the biochemical, electrophysiological, transcriptional, and behavioral effects of DOPAMINE.
| Descriptor ID |
D051937
|
| MeSH Number(s) |
D12.776.631.249 D12.776.744.459
|
| Concept/Terms |
Dopamine and cAMP-Regulated Phosphoprotein 32- Dopamine and cAMP-Regulated Phosphoprotein 32
- Dopamine and cAMP Regulated Phosphoprotein 32
- Dopamine and cAMP-Regulated Phosphoprotein
- Dopamine and cAMP Regulated Phosphoprotein
- DARPP-32 Protein
- DARPP 32 Protein
- Dopamine and Adenosine 3',5'-Monophosphate-Regulated Phosphoprotein
- Dopamine and Adenosine 3',5' Monophosphate Regulated Phosphoprotein
- Dopamine- and Cyclic AMP-Regulated Phosphoprotein Mr 32,000
- Dopamine and Cyclic AMP Regulated Phosphoprotein Mr 32,000
|
Below are MeSH descriptors whose meaning is more general than "Dopamine and cAMP-Regulated Phosphoprotein 32".
Below are MeSH descriptors whose meaning is more specific than "Dopamine and cAMP-Regulated Phosphoprotein 32".
This graph shows the total number of publications written about "Dopamine and cAMP-Regulated Phosphoprotein 32" by people in this website by year, and whether "Dopamine and cAMP-Regulated Phosphoprotein 32" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine and cAMP-Regulated Phosphoprotein 32" by people in Profiles.
-
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis. J Neuroimmunol. 2016 05 15; 294:32-40.
-
Altered palmitoylation and neuropathological deficits in mice lacking HIP14. Hum Mol Genet. 2011 Oct 15; 20(20):3899-909.
-
A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology (Berl). 2009 May; 203(4):703-11.
-
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiol Dis. 2008 Jan; 29(1):22-9.
-
Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology. 2006 May; 31(5):1056-63.
-
NMDA receptors lose their inhibitions. Nat Neurosci. 2002 Jul; 5(7):614-6.
-
Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage. Exp Neurol. 2000 Jan; 161(1):259-72.
-
Immortalized murine striatal neuronal cell lines expressing dopamine receptors and cholinergic properties. J Neurosci. 1995 Jan; 15(1 Pt 2):676-88.
-
Correlated light and electron microscopic study of dopaminergic neurons and their synaptic junctions with DARPP-32-containing cells in three-dimensional reaggregate tissue culture. J Comp Neurol. 1989 Nov 01; 289(1):165-77.